Unknown

Dataset Information

0

A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.


ABSTRACT: Shiga toxin-producing Escherichia coli (STEC) produce two types of Shiga toxin (STx): STx1 and STx2. The toxin A-subunits block protein synthesis, while the B-subunits mediate retrograde trafficking. STEC infections do not have definitive treatments, and there is growing interest in generating toxin transport inhibitors for therapy. However, a comprehensive understanding of the mechanisms of toxin trafficking is essential for drug development. While STx2 is more toxic in vivo, prior studies focused on STx1 B-subunit (STx1B) trafficking. Here, we show that, compared with STx1B, trafficking of the B-subunit of STx2 (STx2B) to the Golgi occurs with slower kinetics. Despite this difference, similar to STx1B, endosome-to-Golgi transport of STx2B does not involve transit through degradative late endosomes and is dependent on dynamin II, epsinR, retromer and syntaxin5. Importantly, additional experiments show that a surface-exposed loop in STx2B (?4-?5 loop) is required for its endosome-to-Golgi trafficking. We previously demonstrated that residues in the corresponding ?4-?5 loop of STx1B are required for interaction with GPP130, the STx1B-specific endosomal receptor, and for endosome-to-Golgi transport. Overall, STx1B and STx2B share a common pathway and use a similar structural motif to traffic to the Golgi, suggesting that the underlying mechanisms of endosomal sorting may be evolutionarily conserved.

SUBMITTER: Selyunin AS 

PROVIDER: S-EPMC4715488 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.

Selyunin Andrey S AS   Mukhopadhyay Somshuvra S  

Traffic (Copenhagen, Denmark) 20151102 12


Shiga toxin-producing Escherichia coli (STEC) produce two types of Shiga toxin (STx): STx1 and STx2. The toxin A-subunits block protein synthesis, while the B-subunits mediate retrograde trafficking. STEC infections do not have definitive treatments, and there is growing interest in generating toxin transport inhibitors for therapy. However, a comprehensive understanding of the mechanisms of toxin trafficking is essential for drug development. While STx2 is more toxic in vivo, prior studies focu  ...[more]

Similar Datasets

| S-EPMC2762141 | biostudies-literature
2020-02-24 | PXD015642 | Pride
| S-EPMC3391278 | biostudies-literature
| S-EPMC7039708 | biostudies-literature
| S-EPMC6599968 | biostudies-literature
| S-EPMC1635369 | biostudies-literature
| S-EPMC5367627 | biostudies-literature
| S-EPMC4445914 | biostudies-literature
| S-EPMC3139239 | biostudies-literature
| S-EPMC1257389 | biostudies-literature